REFERENCE
Pirk O, Hessel F, Kotowa W, Hertel N.Long-term cost-effectiveness of rimonabant in Germany. Value in Health 10: A414-A415 (plus poster) abstr. PCV31, No. 6, Nov-Dec 2007
Rights and permissions
About this article
Cite this article
Rimonabant reimbursement should return in Germany?. Pharmacoecon. Outcomes News 540, 6 (2007). https://doi.org/10.2165/00151234-200705400-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705400-00007